Dendreon Corp (DNDN)
Symbol Info
Listed Symbol DNDN
Name Dendreon Corp
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2013-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $
Price Info
21 Day Moving Average $-
21 Day EMA $-
50 Day Moving Average $-
50 Day EMA $-
200 Day EMA $-
200 Day Moving Average -
52 Week High $
52 Week Low $-
52 Week Change $
Alpha
Beta
Standard Deviation
R2
Periods
Share Information
10 Day Average Volume -
20 Day Average Volume -
30 Day Average Volume -
50 Day Average Volume -
Outstanding Shares 158,716,893
Float Shares 158,716,893
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 32
Institute Holdings Date 2015-04-30
Institute Bought Previous 3 Months 267,351
Institute Holdings Percent 1.700000
Institute Sold Previous 3 Months 21,017,227
Insider Holdings Date 2015-04-30
Insider Bought Previous 3 Months -
Insider Holdings Percent 5.10%
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $-
21 Day Percent Change -
30 Day Price Change $-
30 Day Percent Change -
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $-
90 Day Percent Change -
Quarter To Date $-
Quarter To Date Percent -
180 Day Price Change $-
180 Day Percent Change -
200 Day Price Change $-
200 Day Percent Change -
Year To Date $-
Year To Date Percent -
Profile
Description
Details
Issue Type CS
Market Cap $-
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding -
CEO W. Thomas Amick
Employees 710
Last Audit UQ
Classification
CIK 0001107332
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 1301 2nd Avenue
Seattle, WA 98101
Website http://www.dendreon.com
Facisimile +1 206 256-0571
Telephone +1 206 256-4545
Email ir@dendreon.com
Key Ratios
Profitability
EBIT Margin -6.9
EBITDA Margin 0.8
Pre-Tax Profit Margin -169
Profit Margin Cont -28.12
Gross Margin 52.80
Profit Margin TOT -28.12
Income Statements
Revenue $-
Revenue Per Share $0.9801
Revenue 3 Years $-22.1
Revenue 5 Years $231.80
Valuation Measures
PE Ratio -
Enterprise Value $-
Price To Sales -
Price To Free Cash -0.2
PE High Last 5 Years -
Price To Book 26.1
Price To Cash Flow -0.3
PE Low Last 5 Years -
Price To Tangible Book -0.1
Financial Strength
Total Debt To Equity -
Int Coverage -0.6
Current Ratio 28.0
Leverage Ratio 0.6
Quick Ratio 28.0
Long Term Debt To Capital -
Assets
Receivables Turnover 9.0
Invoice Turnover 2.30
Assets Turnover 0.30
Management Effectiveness
Return Assets -9.6
Return On Equity 22.72
Return On Capital 44.26
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
DNDN
(MM)
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.